China has banned its drug regulators from owning stock in pharmaceutical companies in order to clean up the scandal-plagued industry, AP reported. Drug companies are accused of bribing regulators and paying off doctors and hospitals to use substandard products. Beijing is investigating a former State Food and Drug Administration director accused of taking bribes to approve drugs that were subsequently blamed in a string of deaths. Authorities have ordered a review of thousands of drug licenses to see whether any were improperly granted.
You must log in to post a comment.
Yes, I would like to receive emails from China Economic Review. (You can unsubscribe anytime)
Copyright © 2018 SinoMedia Group Limited All rights reserved